Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
China
· Delayed Price · Currency is CNY 13.55
+0.31 (2.34%)
Apr 29, 2026, 3:00 PM CST
SHA:603108 Revenue
In the year 2025, Shanghai Runda Medical Technology had annual revenue of 7.00B CNY, down -15.80%. Shanghai Runda Medical Technology had revenue of 1.73B in the quarter ending December 31, 2025, a decrease of -18.99%.
Revenue
7.00B
Revenue Growth
-15.80%
P/S Ratio
1.17
Revenue / Employee
2.23M
Employees
3,137
Market Cap
8.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.00B | -1.31B | -15.80% |
| Dec 31, 2024 | 8.31B | -835.59M | -9.13% |
| Dec 31, 2023 | 9.15B | -1.35B | -12.84% |
| Dec 31, 2022 | 10.49B | 1.63B | 18.45% |
| Dec 31, 2021 | 8.86B | 1.79B | 25.33% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amoy Diagnostics | 1.20B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Cowealth Medical China | 656.38M |
| Dian Diagnostics Group | 10.10B |
| Guangzhou Kingmed Diagnostics Group | 5.91B |
| Thalys Medical Technology Group | 1.25B |
| BGI Genomics | 3.84B |